Bleocip (Bleomycin)

Bleocip Bleomycin is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. Bleocip (Bleomycin)
is classified as an “antitumor antibiotic.”Bleocip Bleomycin  drugs act during multiple phases of the cell cycle and are considered cell-cycle specific

Bleocip (Bleomycin) is used  in the treatment of squamous cell cancers, melanoma, sarcoma, testicular cancer, Hodgkin’s and non-Hodgkin’s lymphoma. Also used to treat pleural effusion (build up of fluid in the space between the lining of the lung and the chest wall).

bleocipBLEOCIP
AVAILABLE AS:
15 Unit Ing
MANUFACTURE BY:
CIPLA. (INDIA)

Dosage : Bleocip (Bleomycin)

Squamous Cell Carcinoma

0.25-0.5 unit/kg (10 to 20 unit/m²) IV/IM/SC q1-2Weeks

Hodgkin’s Disease, Non-Hodgkin’s Lymphoma

Administer test dose of 1-2 units of  Bleocip (Bleomycin) before first 1-2 doses; monitor vital signs q15min; wait 1 hour minimum before administering remainder of dose; if no acute reaction observe, may administer regular dosage schedule

0.25 to 0.5 unit/kg (10 to 20 unit/m²) IV/IM/SC q1-2Weeks; reduce to maintenance dose of 1 unit qDay or 5 unit qWeek IV/IM after 50% response

Testicular Carcinoma

Bleocip (Bleomycin) 0.25-0.5 unit/kg (10 to 20 unit/m²) IV/IM/SC q1-2Weeks

Pleural Sclerosing

Bleocip (Bleomycin) 60 unit in 50-100 mL as single instillation; may repeat dose at intervals of several days if fluid continues to accumulate (mix in 50-100 mL or NS); may add lidocaine 100-200 mg to reduce local discomfort

Elderly: May limit dose to 40 unit/m²

For more information on Bleocip (Bleomycin) please click here

Consult your doctor for proper Dosage for yourself


Bleocip (Bleomycin) medicine is to be taken strictly under Supervision of Medical Oncologist Only